Drug Profile
COL 195
Alternative Names: COL-195; Hydrocodone DETERx® - Collegium PharmaceuticalLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Collegium Pharmaceutical
- Class Analgesics; Antitussives; Morphinans; Opioid analgesics; Opioid peptides; Small molecules
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Pain
Most Recent Events
- 01 Oct 2019 COL 195 is still in clinical trials for Pain in USA (Collegium Pharmaceutical website, September 2019)
- 22 Jun 2016 Topline pharmacokinetics data from a clinical trial in Pain released by Collegium Pharmaceutical
- 21 Jan 2016 US FDA approves IND application for Hydrocodone DETERx® in Chronic pain